DE69805787T2 - Verbindungen zur hemmung der magensäuresekretion - Google Patents

Verbindungen zur hemmung der magensäuresekretion

Info

Publication number
DE69805787T2
DE69805787T2 DE69805787T DE69805787T DE69805787T2 DE 69805787 T2 DE69805787 T2 DE 69805787T2 DE 69805787 T DE69805787 T DE 69805787T DE 69805787 T DE69805787 T DE 69805787T DE 69805787 T2 DE69805787 T2 DE 69805787T2
Authority
DE
Germany
Prior art keywords
compound according
pyridine
formula
compounds
dimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69805787T
Other languages
German (de)
English (en)
Other versions
DE69805787D1 (de
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE69805787D1 publication Critical patent/DE69805787D1/de
Publication of DE69805787T2 publication Critical patent/DE69805787T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69805787T 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion Expired - Fee Related DE69805787T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion

Publications (2)

Publication Number Publication Date
DE69805787D1 DE69805787D1 (de) 2002-07-11
DE69805787T2 true DE69805787T2 (de) 2003-01-02

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69805787T Expired - Fee Related DE69805787T2 (de) 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion

Country Status (32)

Country Link
US (1) US6265415B1 (enExample)
EP (1) EP0971920B1 (enExample)
JP (1) JP2001512477A (enExample)
KR (1) KR20000075622A (enExample)
CN (1) CN1100056C (enExample)
AR (1) AR011134A1 (enExample)
AT (1) ATE218569T1 (enExample)
AU (1) AU723389B2 (enExample)
BR (1) BR9807457A (enExample)
CA (1) CA2280008A1 (enExample)
CZ (1) CZ291681B6 (enExample)
DE (1) DE69805787T2 (enExample)
DK (1) DK0971920T3 (enExample)
EE (1) EE04016B1 (enExample)
ES (1) ES2178169T3 (enExample)
HU (1) HUP0000720A3 (enExample)
ID (1) ID22218A (enExample)
IL (1) IL131122A0 (enExample)
IS (1) IS1901B (enExample)
MY (1) MY118822A (enExample)
NO (1) NO313009B1 (enExample)
NZ (1) NZ336878A (enExample)
PL (1) PL190379B1 (enExample)
PT (1) PT971920E (enExample)
RU (1) RU2193036C2 (enExample)
SE (1) SE9700661D0 (enExample)
SK (1) SK283903B6 (enExample)
TR (1) TR199902060T2 (enExample)
TW (1) TW568907B (enExample)
UA (1) UA64741C2 (enExample)
WO (1) WO1998037080A1 (enExample)
ZA (1) ZA981134B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084312A1 (ja) * 2012-11-30 2014-06-05 アステラス製薬株式会社 イミダゾピリジン化合物

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
JPH10502365A (ja) * 1994-07-01 1998-03-03 リカン・リミテッド ヘリコバクタータンパク質およびワクチン
GB2324093A (en) * 1996-01-04 1998-10-14 Rican Limited Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EP1423142A1 (en) * 2001-08-31 2004-06-02 Chiron SRL. Helicobacter pylori vaccination with a combination of caga, vaca and nap proteins
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2499639C (en) 2002-09-19 2011-11-08 Schering Corporation Imidazopyridines as cyclin dependent kinase inhibitors
DK1603570T5 (da) * 2003-02-26 2013-12-09 Sugen Inc Aminoheteroarylforbindelser som proteinkinaseinhibitorer
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
WO2005026164A1 (en) * 2003-09-18 2005-03-24 Altana Pharma Ag Pharmacologically active imidazo[4,5-c]pyridines
CA2544325A1 (en) 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
ATE527258T1 (de) * 2004-07-28 2011-10-15 Takeda Pharmaceutical Pyrroloä2,3-cüpyridinverbindung, verfahren zu deren herstellung und anwendung
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
EP1784402B1 (en) 2004-09-03 2011-08-03 Yuhan Corporation PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF
MX2007002219A (es) * 2004-09-03 2007-05-04 Yuhan Corp Derivados de pirrolo [3,2-b ] piridina y procesos para su preparacion.
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
EP2258350B1 (en) * 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2006100119A1 (en) * 2005-03-24 2006-09-28 Glaxo Group Limited Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases
US7825137B2 (en) 2005-12-05 2010-11-02 Pfizer Inc. Method of treating abnormal cell growth
DK1963302T3 (da) 2005-12-05 2013-04-02 Pfizer Prod Inc Polymorfer af en C-MET/HGFR-inhibitor
FR2903107B1 (fr) * 2006-07-03 2008-08-22 Sanofi Aventis Sa Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique
EP2496578A4 (en) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
EA201391769A1 (ru) 2011-05-30 2014-04-30 Астеллас Фарма Инк. Имидазопиридиновые соединения
CN120117960A (zh) * 2025-05-12 2025-06-10 天津全和诚科技有限责任公司 一种杂质化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084312A1 (ja) * 2012-11-30 2014-06-05 アステラス製薬株式会社 イミダゾピリジン化合物

Also Published As

Publication number Publication date
IS1901B (is) 2003-11-20
CZ301499A3 (cs) 2000-02-16
AR011134A1 (es) 2000-08-02
CZ291681B6 (cs) 2003-04-16
UA64741C2 (uk) 2004-03-15
SK109999A3 (en) 2000-01-18
PL190379B1 (pl) 2005-12-30
AU723389B2 (en) 2000-08-24
DK0971920T3 (da) 2002-09-16
EE9900367A (et) 2000-04-17
BR9807457A (pt) 2000-04-25
EE04016B1 (et) 2003-04-15
SE9700661D0 (sv) 1997-02-25
IS5148A (is) 1999-08-05
CN1100056C (zh) 2003-01-29
CA2280008A1 (en) 1998-08-27
AU6314798A (en) 1998-09-09
TW568907B (en) 2004-01-01
DE69805787D1 (de) 2002-07-11
SK283903B6 (sk) 2004-04-06
PT971920E (pt) 2002-11-29
JP2001512477A (ja) 2001-08-21
TR199902060T2 (xx) 2000-02-21
ES2178169T3 (es) 2002-12-16
NO994078L (no) 1999-08-24
NO313009B1 (no) 2002-07-29
MX9907650A (es) 2002-12-13
HUP0000720A2 (hu) 2000-10-28
EP0971920B1 (en) 2002-06-05
RU2193036C2 (ru) 2002-11-20
HUP0000720A3 (en) 2001-01-29
WO1998037080A1 (en) 1998-08-27
EP0971920A1 (en) 2000-01-19
CN1248257A (zh) 2000-03-22
NZ336878A (en) 2001-05-25
MY118822A (en) 2005-01-31
IL131122A0 (en) 2001-01-28
KR20000075622A (ko) 2000-12-26
ZA981134B (en) 1998-08-25
ID22218A (id) 1999-09-16
PL335485A1 (en) 2000-04-25
HK1024248A1 (en) 2000-10-05
NO994078D0 (no) 1999-08-24
ATE218569T1 (de) 2002-06-15
US6265415B1 (en) 2001-07-24

Similar Documents

Publication Publication Date Title
DE69805787T2 (de) Verbindungen zur hemmung der magensäuresekretion
DE69928792T2 (de) Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen
DE69811735T2 (de) Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon
DE69716904T2 (de) Neue verbindungen
DE69921483T2 (de) Imidazo[1,2-a]pyridin-Verbindungen, die die Magensäuresekretion inhibieren, sie enthaltende pharmazeutische Zusammensetzungen und Verfahren für ihre Herstellung
DE69228142T2 (de) Pyrolo[2,3-b]pyridine mit therapeutischer Wirkung und Verfahren zu deren Herstellung
DE69908608T2 (de) Derivate von Imidazo[1,2-a]pyridin zur Behandlung von gastrointestinalen Krankheiten
DE3533331A1 (de) Pyridothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JP2005501870A (ja) 治療効果を有する新規なイミダゾピリジン化合物
DE602004011773T2 (de) Neue imidazopyridinverbindung ii mit therapeutischer wirkung
EP0555825A1 (de) Imidazo 1,2-a pyridine als Angiotensin-II-Antagonisten
KR100487029B1 (ko) 신규화합물
AU697006C (en) Compounds for inhibition of gastric acid secretion
MXPA97004136A (en) Compounds for inhibition of gastr acid secretion
HK1024248B (en) Compounds for inhibition of gastric acid secretion
EP0796249A1 (en) Compounds for inhibition of gastric acid secretion
MXPA01001720A (en) New compounds
MXPA00010231A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee